1. Rosenfeld SB, Schroeder K, Watkins-Castillo SI. The economic burden of musculoskeletal disease in children and adolescents in the United States. J Pediatr Orthop. 2018;38:e230–6.
2. Sawyer JR, Jones KC, Copley LA. Chambers C and POSNA practice management committee. J Pediatr Orthop. 2017;37:59–66.
3. Holroyd HJ, Cohen JH, Dyment PG, Fost NC, Korsch B, Krugman RD et al. Council on child and adolescent health. Age limits of pediatrics. Pediatrics. 1988;81:736, Available from: http://pediatrics.aappublications.org/content/81/5/736
4. Premarket Assessment of Pediatric Medical Devices. Guidance for industry and food and drug administration staff. Document issued on: March 24, 2014. Available from: https://www.fda.gov/media/73510/download
5. Statement of the American Association of Orthopaedic Surgeons on FDA Medical Device Regulation: Impact on American Patients, Innovation, and Jobs. Committee on Energy and Commerce/Subcommittee on Oversight and Investigations, U.S. House of Representatives, July 20, 2011. Available from: http://www.pwrnewmedia.com/2011/aaos/advocacy_now/special_edition/aug23/downloads/AAOS-POSNA-SRS-statement.pdf